Application of Apoptosis to Cancer Treatment (eBook)
VIII, 370 Seiten
Springer Netherlands (Verlag)
978-1-4020-3302-5 (ISBN)
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients.
Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world's leading experts in these fields.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world's leading experts in these fields.
Chapter 1: Disfunction of the Apoptotic Pathway in Cancer Cells by Lily Yang Chapter 2: Calcium Signaling and Apoptosis Resistance of Cancer Cells by Natalia Prevarskaya, Roman Skryma and Yaroslav Shuba Chapter 3: Cell Clearance and Cancer by Bengt Fadeel Chapter 4: Specific, Pro-Poptotic Cell-Signaling: Design of Novel, Recombinant Targeted Antitumor Agents Operating Exclusively Through Modulation of Cellular Apoptotic Events: Novel, Targeted Pro-Apoptotic Therapeutic Agents by Yuying Liu, Lawrence H. Cheung and Michael G. Rosenblum Chapter 5: Targeting Oncogenes which Regulate Apoptosis by Andrew C. Phillips Chapter 6: Targeting Cyclins to Cause Cancer Cell Apoptosis by Suparna Mazumder, Dragos Plesca and Alexandru Almasan Chapter 7: Apoptosis Induction by Tumor-Targeted Toxins by Andrew Thorburn Chapter 8: Targeting Cell-Death Pathways in Multiple Myeloma: Therapeutic Implications by Dharminder Chauhan and Kenneth Anderson Chapter 9: Cephalostatin 1-Induced Apoptosis in Tumor Cells Selective Induction of Smac/DIABLO Release by Verena M. Dirsch and Angelika M. Vollmar Chapter10: Hamlet; a Novel Tool to Identify Apoptotic Pathways in Tumor Cells 223 by Caroline Düringer, Oskar Hallgren, Lotta Gustafsson, Jenny Petterson, Ann-Kristin Mossberg, Taras Manilov and Catharina Svanborg Chapter 11: Cancer Immunotherapy: On the Trail of a Cure? by Thomas S. Griffith, Troy J. Kemp1, Aaron T. Ludwig, Jill M. Moore, and Rebecca L. VanOosten Chapter 12: Histone Deacetylase Inhibitors as a Treatment of Trail-Resistant Cancers by Jiri Neuzil, Ladislav Andera and Brian Gabrielli Chapter 13: Basis of Cell Kill Following Clinical Radiotherapy by Oliver Faulhaber and Robert G Bristow Chapter 14: Imaging of Apoptotic Cells in Vivo by Juhana Hakumäki Chapter15: Apoptosis-Inducing Anticancer Drugs in Clinical Trials by Wei Hu and John J. Kavanagh
Erscheint lt. Verlag | 14.7.2005 |
---|---|
Zusatzinfo | VIII, 370 p. |
Verlagsort | Dordrecht |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Studium | |
Naturwissenschaften ► Biologie | |
Technik | |
Schlagworte | Apoptosis • Cancer • Cancer Treatment • Cell • cell death • clinical trial • Drugs • Endoplasmatisches Reticulum • Imaging • immunotherapy • Oncogenes • Programmed Cell Death • Research • resistance • Vivo |
ISBN-10 | 1-4020-3302-8 / 1402033028 |
ISBN-13 | 978-1-4020-3302-5 / 9781402033025 |
Haben Sie eine Frage zum Produkt? |
![PDF](/img/icon_pdf_big.jpg)
Größe: 10,5 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich